EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival

Yuji Sakuma iD, Sachie Hirai, Miki Yamaguchi, Masashi Idogawa iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yuji Sakuma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Research Institute for Immunology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan. Hauptthemen laut MEDLINE: Kinesins, Small Cell Lung Carcinoma, Lung Neoplasms, Cell Survival. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research from JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few efficacious treatment options are available for patients with small cell lung carcinoma (SCLC), indicating the need to develop novel therapeutic approaches. In this study, we explored kinesin family member 11 (KIF11), a potential therapeutic target in SCLC. An analysis of publicly available data suggested that KIF11 mRNA expression levels are significantly higher in SCLC tissues than in normal lung tissues. When KIF11 was targeted by RNA interference or a small-molecule inhibitor (SB743921) in two SCLC cell lines, Lu-135 and NCI-H69, cell cycle progression was arrested at the G2/M phase with complete growth suppression. Further work suggested that the two cell lines were more significantly affected when both KIF11 and BCL2L1, an anti-apoptotic BCL2 family member, were inhibited. This dual inhibition resulted in markedly decreased cell viability. These findings collectively indicate that SCLC cells are critically dependent on KIF11 activity for survival and/or proliferation, as well as that KIF11 inhibition could be a new strategy for SCLC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KinesinsSmall Cell Lung CarcinomaLung NeoplasmsCell SurvivalHumansCell Line, TumorCell Proliferationbcl-X ProteinGene Expression Regulation, NeoplasticApoptosisBenzamidesQuinazolines

Stichwörter der Autor:innen

BCL2-like 1 (BCL2L1)apoptosiskinesin family member 11 (KIF11)small cell lung cancer (SCLC)

Substanzen

KinesinsKIF11 protein, humanbcl-X ProteinBCL2L1 protein, humanispinesibBenzamidesQuinazolines

Autor:innen und Institutionen

  • Department of Molecular Medicine, Research Institute for Immunology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.

ORCID-Profile: Yuji Sakuma, Masashi Idogawa

Förderung

  • Japan Society for the Promotion of Science
  • Grants-in-Aid for Scientific Research from JSPS

Zitieren

APA

Sakuma, Y., Hirai, S., Yamaguchi, M., & Idogawa, M. (2024). Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137230

Vancouver

Sakuma Y, Hirai S, Yamaguchi M, Idogawa M. Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137230

BibTeX
@article{Sakuma2024,
  author = {Sakuma, Yuji and Hirai, Sachie and Yamaguchi, Miki and Idogawa, Masashi},
  title = {Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137230}
}
Kostenlos starten →